John Schaetzl

Chairman at

Stichting Access To Medicine Foundation

Consumer Services

Finance

Health Technology

Profile

John Schaetzl is currently the Chairman-Supervisory Board at Stichting Access To Medicine Foundation.
Previously, he worked as a Research Vice President at GE Asset Management, Inc. from 1998 to 2008.
He also worked as a Principal at Miles Laboratories, Inc. Mr. Schaetzl received his undergraduate degree from Harvard University and his graduate degree from the University of Pennsylvania.

John Schaetzl active positions

Companies	Position	Start
Stichting Access To Medicine Foundation Stichting Access To Medicine Foundation Miscellaneous Commercial ServicesCommercial Services Engages in stimulating and guiding pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine	Chairman	-

All active positions of John Schaetzl

Former positions of John Schaetzl

Companies	Position	End
GE Asset Management, Inc. GE Asset Management, Inc. Investment ManagersFinance GE Asset Management's (GEAM) core investment strategies include US equities, international equities, fixed-income, real estate and private equity. The firm follows a disciplined, fundamental, bottom-up approach to investing in US equities. Their US equity investment approach involves rigorous analyses of financial data, including industry, sector and company information, as well as qualitative assessments of management and their ability to execute business plans. Generally, GEAM invests in companies that are industry leaders with high quality earnings and a history of creating shareholder value. GEAM's international equities approach includes a variety of strategies such as International Equity, Global Equity and Emerging Markets Equity, as well as regional and country specific mandates for Canada, Europe, Euroland, China and India. All strategies are driven by a bottom-up, fundamental research process. GEAM's fixed-income team manages a variety of investment styles and strategies that span the yield curve and credit quality universe. The firm manages a variety of products designed to meet various customer risk/return parameters. GEAM's fixed-income team follows a relative value approach, emphasizing a fundamental, bottom-up process with the objective of enhancing returns while limiting volatility. The firm's International Private Equity team invests in companies domiciled and doing a substantial portion of their business outside of the US. They focus primarily on corporate buyouts and growth-equity investments, but they also selectively consider later-stage venture capital investments. GEAM considers investment opportunities across a broad range of industrial sectors and geographic areas and pursues potential investment opportunities in both developed and emerging markets.	Analyst-Equity	2008-10-30
Miles Laboratories, Inc. Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Sales & Marketing	1997-12-30

See the detail of John Schaetzl's experience

Training of John Schaetzl

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Schaetzl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
GE Asset Management, Inc. GE Asset Management, Inc. Investment ManagersFinance GE Asset Management's (GEAM) core investment strategies include US equities, international equities, fixed-income, real estate and private equity. The firm follows a disciplined, fundamental, bottom-up approach to investing in US equities. Their US equity investment approach involves rigorous analyses of financial data, including industry, sector and company information, as well as qualitative assessments of management and their ability to execute business plans. Generally, GEAM invests in companies that are industry leaders with high quality earnings and a history of creating shareholder value. GEAM's international equities approach includes a variety of strategies such as International Equity, Global Equity and Emerging Markets Equity, as well as regional and country specific mandates for Canada, Europe, Euroland, China and India. All strategies are driven by a bottom-up, fundamental research process. GEAM's fixed-income team manages a variety of investment styles and strategies that span the yield curve and credit quality universe. The firm manages a variety of products designed to meet various customer risk/return parameters. GEAM's fixed-income team follows a relative value approach, emphasizing a fundamental, bottom-up process with the objective of enhancing returns while limiting volatility. The firm's International Private Equity team invests in companies domiciled and doing a substantial portion of their business outside of the US. They focus primarily on corporate buyouts and growth-equity investments, but they also selectively consider later-stage venture capital investments. GEAM considers investment opportunities across a broad range of industrial sectors and geographic areas and pursues potential investment opportunities in both developed and emerging markets.	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Miles Laboratories, Inc. Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Stichting Access To Medicine Foundation Stichting Access To Medicine Foundation Miscellaneous Commercial ServicesCommercial Services Engages in stimulating and guiding pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine	Commercial Services